{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:06:44Z","timestamp":1794254804785,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Esophageal squamous cell carcinoma (ESCC) patients often face a grim prognosis due to lymph node metastasis. However, a comprehensive understanding of the cellular and molecular characteristics of metastatic lymph nodes in ESCC remains elusive. In this study involving 12 metastatic ESCC patients, we employed single-cell sequencing, spatial transcriptomics (ST), and multiplex immunohistochemistry (mIHC) to explore the spatial and molecular attributes of primary tumor samples, adjacent tissues, metastatic and non-metastatic lymph nodes. The analysis of 161,333 cells revealed specific subclusters of epithelial cells that were significantly enriched in metastatic lymph nodes, suggesting pro-metastatic characteristics. Furthermore, stromal cells in the tumor microenvironment, including MMP3\n                    <jats:sup>+<\/jats:sup>\n                    IL24\n                    <jats:sup>+<\/jats:sup>\n                    fibroblasts, APLN\n                    <jats:sup>+<\/jats:sup>\n                    endothelial cells, and CXCL12\n                    <jats:sup>+<\/jats:sup>\n                    pericytes, were implicated in ESCC metastasis through angiogenesis, collagen production, and inflammatory responses. Exhausted CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in a cycling status were notably prevalent in metastatic lymph nodes, indicating their potential role in facilitating metastasis. We identified distinct cell-cell communication networks and specific ligand-receptor pathways. Our findings were validated through a spatial transcriptome map and mIHC. This study enhances our comprehension of the cellular and molecular aspects of metastatic lymph nodes in ESCC patients, offering potential insights into novel therapeutic strategies for these individuals.\n                  <\/jats:p>","DOI":"10.1038\/s12276-024-01369-x","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T20:02:11Z","timestamp":1735675331000},"page":"59-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases"],"prefix":"10.1038","volume":"57","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhou","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Huai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4211-552X","authenticated-orcid":false,"given":"Shugeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,1]]},"reference":[{"key":"1369_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1369_CR2","doi-asserted-by":"publisher","unstructured":"Zhou, B. et al. Global burden and temporal trends in incidence and mortality of oesophageal cancer. J. Adv. Res., https:\/\/doi.org\/10.1016\/j.jare.2022.10.007 (2022).","DOI":"10.1016\/j.jare.2022.10.007"},{"key":"1369_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology 163, 649\u2013658.e642 (2022).","journal-title":"Gastroenterology"},{"key":"1369_CR4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/SLA.0000000000002118","volume":"267","author":"Y Baba","year":"2018","unstructured":"Baba, Y. et al. Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study. Ann. Surg. 267, 478\u2013483 (2018).","journal-title":"Ann. Surg."},{"key":"1369_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gutjnl-2013-306388","volume":"64","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma. Gut. 64, 26\u201336 (2015).","journal-title":"Gut."},{"key":"1369_CR6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(17)30181-X","volume":"18","author":"T Kudo","year":"2017","unstructured":"Kudo, T. et al. Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial. Lancet Oncol. 18, 631\u2013639 (2017).","journal-title":"Lancet Oncol."},{"key":"1369_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","volume":"326","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial. JAMA 326, 916\u2013925 (2021).","journal-title":"JAMA"},{"key":"1369_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccell.2022.02.007","volume":"40","author":"ZX Wang","year":"2022","unstructured":"Wang, Z. X. et al. Toripalimab plus chemotherapy in treatment-na\u00efve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial. Cancer Cell 40, 277\u2013288.e273 (2022).","journal-title":"Cancer Cell"},{"key":"1369_CR9","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat. Commun. 11, 6268 (2020).","journal-title":"Nat. Commun."},{"key":"1369_CR10","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang, H. et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol. Cancer 19, 41 (2020).","journal-title":"Mol. Cancer"},{"key":"1369_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"1369_CR12","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 169, 1342\u20131356.e1316 (2017).","journal-title":"Cell"},{"key":"1369_CR13","doi-asserted-by":"crossref","first-page":"106800","DOI":"10.1016\/j.phrs.2023.106800","volume":"192","author":"B Zhou","year":"2023","unstructured":"Zhou, B. et al. Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma. Pharm. Res 192, 106800 (2023).","journal-title":"Pharm. Res"},{"key":"1369_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","volume":"40","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell 40, 424\u2013437.e425 (2022).","journal-title":"Cancer Cell"},{"key":"1369_CR15","doi-asserted-by":"crossref","first-page":"103459","DOI":"10.1016\/j.ebiom.2021.103459","volume":"69","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma. EBioMedicine 69, 103459 (2021).","journal-title":"EBioMedicine"},{"key":"1369_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao, A., Barkley, D., Fran\u00e7a, G. S. & Yanai, I. Exploring tissue architecture using spatial transcriptomics. Nature 596, 211\u2013220 (2021).","journal-title":"Nature"},{"key":"1369_CR17","doi-asserted-by":"crossref","first-page":"104281","DOI":"10.1016\/j.ebiom.2022.104281","volume":"84","author":"W Guo","year":"2022","unstructured":"Guo, W. et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. EBioMedicine 84, 104281 (2022).","journal-title":"EBioMedicine"},{"key":"1369_CR18","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"1369_CR19","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"1369_CR20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"1369_CR21","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1093\/nar\/gkt660","volume":"41","author":"G Yaari","year":"2013","unstructured":"Yaari, G., Bolen, C. R., Thakar, J. & Kleinstein, S. H. Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations. Nucleic Acids Res. 41, e170 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1369_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet 25, 25\u201329 (2000).","journal-title":"Nat. Genet"},{"key":"1369_CR23","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici, S. et al. A systems biology approach for pathway level analysis. Genome Res. 17, 1537\u20131545 (2007).","journal-title":"Genome Res."},{"key":"1369_CR24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"1369_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52\u201367 (2010).","journal-title":"Cell"},{"key":"1369_CR26","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1158\/0008-5472.CAN-10-2615","volume":"70","author":"YH Wu","year":"2010","unstructured":"Wu, Y. H. et al. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res. 70, 10422\u201310432 (2010).","journal-title":"Cancer Res."},{"key":"1369_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","volume":"31","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. The CXCL8-CXCR1\/2 pathways in cancer. Cytokine Growth Factor Rev. 31, 61\u201371 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1369_CR28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng, Q. et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat. Rev. Cancer 23, 544\u2013564 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"1369_CR29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10456-013-9349-6","volume":"16","author":"A Kasai","year":"2013","unstructured":"Kasai, A. et al. Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis. Angiogenesis 16, 723\u2013734 (2013).","journal-title":"Angiogenesis"},{"key":"1369_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-020-01650-7","volume":"39","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling. J. Exp. Clin. Cancer Res. 39, 148 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1369_CR31","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","volume":"142","author":"H Pan","year":"2020","unstructured":"Pan, H. et al. Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human. Circulation 142, 2060\u20132075 (2020).","journal-title":"Circulation"},{"key":"1369_CR32","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher, B. A. & Fricker, S. P. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin. Cancer Res. 16, 2927\u20132931 (2010).","journal-title":"Clin. Cancer Res."},{"key":"1369_CR33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1369_CR34","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu, X., Tian, W., Wang, Z., Zhang, J. & Zhou, R. Co-inhibition of TIGIT and PD-1\/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials. Mol. Cancer 22, 93 (2023).","journal-title":"Mol. Cancer"},{"key":"1369_CR35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","volume":"38","author":"PA Savage","year":"2020","unstructured":"Savage, P. A., Klawon, D. E. J. & Miller, C. H. Regulatory T Cell Development. Annu Rev. Immunol. 38, 421\u2013453 (2020).","journal-title":"Annu Rev. Immunol."},{"key":"1369_CR36","doi-asserted-by":"crossref","first-page":"e1314424","DOI":"10.1080\/2162402X.2017.1314424","volume":"6","author":"M Musella","year":"2017","unstructured":"Musella, M., Manic, G., De Maria, R., Vitale, I. & Sistigu, A. Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications. Oncoimmunology 6, e1314424 (2017).","journal-title":"Oncoimmunology"},{"key":"1369_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-022-02339-9","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p. J. Exp. Clin. Cancer Res. 41, 111 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1369_CR38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e723 (2021).","journal-title":"Cell"},{"key":"1369_CR39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","volume":"79","author":"J Tan","year":"2023","unstructured":"Tan, J. et al. TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. J. Hepatol. 79, 126\u2013140 (2023).","journal-title":"J. Hepatol."},{"key":"1369_CR40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495\u2013499 (2017).","journal-title":"Nature"},{"key":"1369_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41423-022-00966-y","volume":"20","author":"Q Song","year":"2023","unstructured":"Song, Q. et al. Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization. Cell Mol. Immunol. 20, 143\u2013157 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"1369_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2018.01.059","volume":"420","author":"H Wu","year":"2018","unstructured":"Wu, H. et al. Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer Cells. Cancer Lett. 420, 156\u2013167 (2018).","journal-title":"Cancer Lett."},{"key":"1369_CR43","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan, J. M. et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 39, 1479\u20131496.e1418 (2021).","journal-title":"Cancer Cell"},{"key":"1369_CR44","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis. Nat. Commun. 12, 5291 (2021).","journal-title":"Nat. Commun."},{"key":"1369_CR45","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/s41388-019-0873-8","volume":"38","author":"L Li","year":"2019","unstructured":"Li, L. et al. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene 38, 6241\u20136255 (2019).","journal-title":"Oncogene"},{"key":"1369_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pharmthera.2018.09.007","volume":"194","author":"MK Jolly","year":"2019","unstructured":"Jolly, M. K. et al. Hybrid epithelial\/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharm. Ther. 194, 161\u2013184 (2019).","journal-title":"Pharm. Ther."},{"key":"1369_CR47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582\u2013598 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1369_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-020-00275-8","volume":"5","author":"HF Hu","year":"2020","unstructured":"Hu, H. F. et al. Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance. Signal Transduct. Target Ther. 5, 271 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1369_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-017-0495-3","volume":"36","author":"HW Cheng","year":"2017","unstructured":"Cheng, H. W. et al. Cancer cells increase endothelial cell tube formation and survival by activating the PI3K\/Akt signalling pathway. J. Exp. Clin. Cancer Res. 36, 27 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1369_CR50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI128469","volume":"130","author":"AG Masoud","year":"2020","unstructured":"Masoud, A. G. et al. Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury. J. Clin. Invest 130, 94\u2013107 (2020).","journal-title":"J. Clin. Invest"},{"key":"1369_CR51","doi-asserted-by":"publisher","unstructured":"Frisch, A. et al. Apelin Controls Angiogenesis-Dependent Glioblastoma Growth. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21114179 (2020).","DOI":"10.3390\/ijms21114179"},{"key":"1369_CR52","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809266","volume":"11","author":"I Uribesalgo","year":"2019","unstructured":"Uribesalgo, I. et al. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy. EMBO Mol. Med. 11, e9266 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1369_CR53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32255-7","volume":"13","author":"M Papanicolaou","year":"2022","unstructured":"Papanicolaou, M. et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat. Commun. 13, 4587 (2022).","journal-title":"Nat. Commun."},{"key":"1369_CR54","volume":"9","author":"N Wang","year":"2018","unstructured":"Wang, N. et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-\u03baB\/SOX4 signaling. Cell Death Dis. 9, 880 (2018).","journal-title":"Cell Death Dis."},{"key":"1369_CR55","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/s41388-021-01654-3","volume":"40","author":"JK Pan","year":"2021","unstructured":"Pan, J. K. et al. MiR-211 determines brain metastasis specificity through SOX11\/NGN2 axis in triple-negative breast cancer. Oncogene 40, 1737\u20131751 (2021).","journal-title":"Oncogene"},{"key":"1369_CR56","doi-asserted-by":"publisher","unstructured":"Leal, J. M. et al. Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation. Sci. Immunol. 6, https:\/\/doi.org\/10.1126\/sciimmunol.abb9435 (2021).","DOI":"10.1126\/sciimmunol.abb9435"},{"key":"1369_CR57","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.7150\/ijbs.70137","volume":"18","author":"D Rong","year":"2022","unstructured":"Rong, D. et al. MGP promotes CD8(+) T cell exhaustion by activating the NF-\u03baB pathway leading to liver metastasis of colorectal cancer. Int. J. Biol. Sci. 18, 2345\u20132361 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1369_CR58","volume":"14","author":"L Gong","year":"2023","unstructured":"Gong, L. et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. Nat. Commun. 14, 1912 (2023).","journal-title":"Nat. Commun."},{"key":"1369_CR59","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1158\/1535-7163.MCT-17-0339","volume":"16","author":"SMP Vadevoo","year":"2017","unstructured":"Vadevoo, S. M. P. et al. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity. Mol. Cancer Ther. 16, 2803\u20132816 (2017).","journal-title":"Mol. Cancer Ther."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01369-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:56:47Z","timestamp":1740131807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01369-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1038\/s12276-024-01369-x","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the National Cancer Center\/Cancer Hospital Ethics Committee (Approval number: 21\/215-2886). All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}